Adaptive Biotechnologies Corporation (ADPT)
USD 5.97
(-8.44%)
USD 5.97
(-8.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 170.27 Million | 185.3 Million | 154.34 Million | 98.38 Million | 85.07 Million | 55.66 Million |
| Cost of Revenue | 75.55 Million | 57.9 Million | 49.3 Million | 22.53 Million | 22.27 Million | 19.66 Million |
| Gross Profit | 94.72 Million | 127.39 Million | 105.04 Million | 75.85 Million | 62.79 Million | 35.99 Million |
| Operating Expenses | 321.75 Million | 327.58 Million | 314 Million | 228.66 Million | 141.18 Million | 85.75 Million |
| Selling, General and Administrative Expenses | 172.51 Million | 184.13 Million | 169.96 Million | 110.89 Million | 68.78 Million | 44.89 Million |
| Research and Development Expenses | 122.11 Million | 141.75 Million | 142.34 Million | 116.07 Million | 70.7 Million | 39.15 Million |
| Other Expenses | 27.12 Million | 1.69 Million | 1.69 Million | 1.7 Million | 1.69 Million | 1.69 Million |
| Cost and Expenses | 397.31 Million | 385.49 Million | 363.31 Million | 251.19 Million | 163.46 Million | 105.41 Million |
| Operating Income | -227.03 Million | -200.18 Million | -208.96 Million | -152.81 Million | -78.39 Million | -49.75 Million |
| Interest Expense | 13.8 Million | 4.23 Million | - | - | - | - |
| Income Tax Expense | - | -57.9 Million | -1.68 Million | -6.59 Million | -9.78 Million | 3.3 Million |
| Earnings before Tax | -225.3 Million | -200.36 Million | -207.29 Million | -146.22 Million | -68.6 Million | -46.44 Million |
| Net Income | -225.25 Million | -142.46 Million | -205.61 Million | -139.63 Million | -58.82 Million | -46.44 Million |
| Earnings Per Share Basic | -1.56 | -1.00 | -1.46 | -1.06 | -0.85 | -0.44 |
| Earnings Per Share Diluted | -1.56 | -1.00 | -1.46 | -1.06 | -0.85 | -0.44 |
| Weighted Average Shares Outstanding | 144.38 Million | 142.51 Million | 140.35 Million | 131.21 Million | 69.16 Million | 105.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 144.38 Million | 142.51 Million | 140.35 Million | 131.21 Million | 69.16 Million | 105.43 Million |
| Gross Margin | 0.56 | 0.69 | 0.68 | 0.77 | 0.74 | 0.65 |
| EBIT Margin | -1.11 | -1.05 | -1.34 | -1.54 | -0.90 | -0.79 |
| Profit Margin | -1.32 | -0.77 | -1.33 | -1.42 | -0.69 | -0.83 |
| EBITDA | -189.27 Million | -167.98 Million | -193.34 Million | -144.34 Million | -70.6 Million | -43.75 Million |
| Earnings Before Tax Margin | -1.33 | -1.08 | -1.35 | -1.55 | -0.92 | -0.89 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 43.19 Million | 41.87 Million | 45.78 Million | 170.27 Million | 37.91 Million | 48.92 Million |
| Cost of Revenue | 22.1 Million | 18.05 Million | 25 Million | 97.78 Million | 19.34 Million | 17.91 Million |
| Gross Profit | 21.08 Million | 23.82 Million | 20.77 Million | 72.49 Million | 18.57 Million | 31.01 Million |
| Operating Expenses | 60.52 Million | 72.58 Million | 66.41 Million | 274.09 Million | 69.52 Million | 78.83 Million |
| Selling, General and Administrative Expenses | 37.52 Million | 41.91 Million | 42.63 Million | - | 40.56 Million | 46.17 Million |
| Research and Development Expenses | 22.99 Million | 30.24 Million | 23.78 Million | - | 28.53 Million | 32.23 Million |
| Other Expenses | 7.62 Million | 423 Thousand | 25.85 Million | 27.12 Million | 428 Thousand | 423 Thousand |
| Cost and Expenses | 82.62 Million | 90.63 Million | 91.42 Million | 371.88 Million | 88.87 Million | 96.74 Million |
| Operating Income | -39.43 Million | -48.76 Million | -45.63 Million | -201.6 Million | -50.95 Million | -47.81 Million |
| Interest Expense | 2.69 Million | 2.99 Million | 3.01 Million | 13.8 Million | -3.65 Million | 3.6 Million |
| Income Tax Expense | -26 Thousand | 4.19 Million | -26 Thousand | -54 Thousand | -5.76 Million | 3.61 Million |
| Earnings before Tax | -46.24 Million | -47.53 Million | -69.46 Million | -225.3 Million | -50.3 Million | -47.81 Million |
| Net Income | -46.22 Million | -47.5 Million | -69.44 Million | -225.25 Million | -50.3 Million | -47.81 Million |
| Earnings Per Share Basic | -0.31 | -0.33 | -0.48 | - | -0.35 | -0.33 |
| Earnings Per Share Diluted | -0.31 | -0.33 | -0.48 | - | -0.35 | -0.33 |
| Weighted Average Shares Outstanding | 147.41 Million | 145.78 Million | 144.9 Million | 144.38 Million | 144.7 Million | 144.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 147.41 Million | 145.78 Million | 144.9 Million | 144.38 Million | 144.7 Million | 144.39 Million |
| Gross Margin | 0.49 | 0.57 | 0.45 | 0.43 | 0.49 | 0.63 |
| EBIT Margin | -0.80 | -0.94 | -0.88 | - | -1.34 | -0.79 |
| Profit Margin | -1.07 | -1.13 | -1.52 | -1.32 | -1.33 | -0.98 |
| EBITDA | -34.43 Million | -39.32 Million | -40.24 Million | - | -50.95 Million | -38.55 Million |
| Earnings Before Tax Margin | -0.91 | -1.16 | -1.00 | -1.18 | -1.34 | -0.98 |
HCI
REPYF
YFI
POW
EXSPF
YAMCF